Hani Jokhdar

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · Trials · 2020 · 132 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward

Abdullah M. Assiri, Jaffar A. Al‐Tawfiq, Monira Alkhalifa et al. · Travel Medicine and Infectious Disease · 2021 · 119 citations · Full text

Public Affairs, Health Policy, Infectious Diseases +14

Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia

Hail M. Al-Abdely, Claire M. Midgley, Abdulrahim M. Alkhamis et al. · Emerging infectious diseases · 2019 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · New England Journal of Medicine · 2020 · 80 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals

Haleema Alserehi, Ada Alqunaibet, Jaffar A. Al‐Tawfiq et al. · Diagnostic Microbiology and Infectious Disease · 2020 · 75 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +3